Biotech Values

[zipjet]

Briefing.com (MNTA) Ticker Alert for In Play



29-Feb-08 11:06 ET

Momenta Pharma: Color on stock action (9.60 +1.70)

Stock is trading up ~20% today with Bloomberg reporting that Novartis (NVS)
executives suggested at a meeting last night that it and partner MNTA are
optimistic US regulators will clear their version of Sanofi's (SNY) Lovenox
anti-clot medicine, Mirabaud. "Prospects of a generic Lovenox sometime in late
2008 are more encouraging than they were." In November, the FDA rejected
MNTA's bid for approval of the drug M-Enoxaparin... We also note that MNTA was
upgraded to Outperform from Underperform this morning.